Legal Action
Page 1 • 2 itemsTrack global pharma legal actions, patent litigation, regulatory challenges, and IP disputes impacting drug development and market access. Stay informed.
ImmunityBio Faces Securities Fraud Lawsuit Over Anktiva Off-Label Promotion After FDA Warning Letter
ImmunityBio hit with class action lawsuit after FDA determined company made false claims about Anktiva bladder cancer drug's capabilities beyond approved use.
Atara Biotherapeutics Class Action Lawsuit Filed: ATRA Stockholders May Recover Investment Losses from May 2024-January 2026
Robbins LLP announces class action lawsuit for Atara Biotherapeutics (ATRA) investors who purchased securities between May 20, 2024 and January 9, 2026.